EPB41 p.Pro291Ser
c.871C>T · rs142874233 · VCV618089
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7862 | likely pathogenic |
|---|---|---|
| REVEL | 0.427 | indeterminate |
| SaProt | LLR -12.54 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.8, phastCons 1 |
| Regional constraint | o/e 0.90 | unconstrained · MANE · 31 kb · p 0.042 · regional, not allelic |
| Overall | ||
| CADD | 25.7 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 5.57% | 18 |
| Middle Easterngrpmax | 1.99% | 50 |
| Remaining individualsnot grpmax-eligible | 0.904% | 111 |
| South Asian | 0.609% | 164 |
| European (non-Finnish) | 0.507% | 197 |
| Admixed American | 0.238% | 419 |
| African / African-American | 0.132% | 757 |
| Finnishnot grpmax-eligible | 0.119% | 842 |
| East Asian | 0.00446% | 22,401 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EPB41
- Protein
- p.Pro291Ser
- Coding
- c.871C>T
- MANE Select
- NM_001376013
- dbSNP
- rs142874233
- Type
- single nucleotide variant
- Location
- chr1:29015733 (GRCh38)
- Gene constraint
- LOEUF 0.738 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.72 · 3 PDB
- Residue 291
- the ferm domain
Disease context
elliptocytosis 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hereditary elliptocytosis (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-5 / 10 000 (Worldwide)
Similar variants
- EPB41 p.Arg471Ter Pathogenic/Likely pathogenic ★★ same condition
- EPB41 p.Arg554Ter Pathogenic/Likely pathogenic ★★ same condition
- EPB41 p.Arg715Ter Pathogenic ★★ same condition
- EPB41 p.Gln274Ter Pathogenic ★★ same condition
- EPB41 p.Tyr331Ter Pathogenic/Likely pathogenic ★★ same condition
- EPB41 p.Ala259Val Uncertain significance ★★ ⚠ same condition
- EPB41 p.Ala502Val Uncertain significance ★★ ⚠ same condition
- EPB41 p.Ala535Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/epb41-p-pro291ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown